| Mean | SD | Phenotype | Prevalence (%) |
---|
Age (yr) | 37.11 | 10.91 | HTG | 31.1 |
BMI (kg/m2) | 28.20 | 4.40 | HW | 27.8 |
WC (cm) | 96.15 | 12.26 | Decreased HDL-C | 45.6 |
SBP (mmHg) | 126.29 | 11.02 | Abdominal obesity | 31.3 |
DBP (mmHg) | 80.11 | 7.38 | Obesity | 29.3 |
TC (mg/dl) | 187.45 | 40.75 | IFG | 18.0 |
LDL-C (mg/dl) | 118.52 | 34.89 | MS | 24.1 |
HDL-C (mg/dl) | 41.25 | 10.66 | | |
TG (mg/dl) | 138.77 | 95.97 | | |
LAP | 52.74 | 6.72 | | |
TG/HDL-C | 3.86 | 3.73 | | |
FPG (mg/dl) | 91.87 | 12.23 | | |
Fasting insulin | 16.18 | 9.27 | | |
HOMA-IR | 2.07 | 1.16 | | |
- n = 724. DBP, diastolic blood pressure; FPG, fasting plasma glucose; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment of insulin resistance; HW, hypertriglyceridemic waist; IR, insulin resistance; LDL-C, low-density lipoprotein cholesterol; SBP, systolic blood pressure; TC, total cholesterol; TG, triglycerides; LAP = lipid accumulation product; WC, waist circumference; HTG = Hypertriglyceridemia; HW = hypertriglyceridemic waist; IFG = impaired fasting glucosa; MS = metabolic syndrome